Cargando…
GLUT3 inhibitor discovery through in silico ligand screening and in vivo validation in eukaryotic expression systems
The passive transport of glucose and related hexoses in human cells is facilitated by members of the glucose transporter family (GLUT, SLC2 gene family). GLUT3 is a high-affinity glucose transporter primarily responsible for glucose entry in neurons. Changes in its expression have been implicated in...
Autores principales: | Iancu, Cristina V., Bocci, Giovanni, Ishtikhar, Mohd, Khamrai, Moumita, Oreb, Mislav, Oprea, Tudor I., Choe, Jun-yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791944/ https://www.ncbi.nlm.nih.gov/pubmed/35082341 http://dx.doi.org/10.1038/s41598-022-05383-9 |
Ejemplares similares
-
Identification of new GLUT2-selective inhibitors through in silico ligand screening and validation in eukaryotic expression systems
por: Schmidl, Sina, et al.
Publicado: (2021) -
Establishing a yeast-based screening system for discovery of human GLUT5 inhibitors and activators
por: Tripp, Joanna, et al.
Publicado: (2017) -
Functional Expression of the Human Glucose Transporters GLUT2 and GLUT3 in Yeast Offers Novel Screening Systems for GLUT-Targeting Drugs
por: Schmidl, Sina, et al.
Publicado: (2021) -
Ligand Screening Systems for Human Glucose Transporters as Tools in Drug Discovery
por: Schmidl, Sina, et al.
Publicado: (2018) -
Discovery of a specific inhibitor of human GLUT5 by virtual screening and in vitro transport evaluation
por: George Thompson, Alayna M., et al.
Publicado: (2016)